Gene · 3381
Papers4,417
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
301 to 320 of 4,417
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| The role of non-coding RNAs in extracellular vesicles in breast cancer and their diagnostic implications. | Oncogene | 2023 | 37670020 | PubTator, text mining | PubMed |
| Revealing the developmental origin and lineage predilection of neural progenitors within human bone marrow via single-cell analysis: implications for regenerative medicine. | Genome Med | 2023 | 37667405 | PubTator, text mining | PubMed |
| Carboxypeptidase E is a prognostic biomarker co-expressed with osteoblastic genes in osteosarcoma. | PeerJ | 2023 | 37663298 | PubTator, text mining | PubMed |
| Magnetic coupling between Fe(NO) spin probe ligands through diamagnetic NiII, PdII and PtII tetrathiolate bridges. | Chem Sci | 2023 | 37655023 | PubTator, text mining | PubMed |
| Identification of an endoplasmic reticulum stress-related prognostic risk model with excellent prognostic and clinical value in oral squamous cell carcinoma. | Aging (Albany NY) | 2023 | 37647077 | PubTator, text mining | PubMed |
| Osteogenic induction of asiatic acid derivatives in human periodontal ligament stem cells. | Sci Rep | 2023 | 37644086 | PubTator, text mining | PubMed |
| Single-cell RNA-seq analysis reveals that immune cells induce human nucleus pulposus ossification and degeneration. | Front Immunol | 2023 | 37638033 | PubTator, text mining | PubMed |
| Pan-cancer analysis reveals the potential of hyaluronate synthase as therapeutic targets in human tumors. | Heliyon | 2023 | 37636435 | PubTator, text mining | PubMed |
| Osteogenic effects of covalently tethered rhBMP-2 and rhBMP-9 in an MMP-sensitive PEG hydrogel nanocomposite. | Acta Biomater | 2023 | 37634836 | PubTator, text mining | PubMed |
| The functional effects of Piezo channels in mesenchymal stem cells. | Stem Cell Res Ther | 2023 | 37633928 | PubTator, text mining | PubMed |
| Host DNA Demethylation Induced by DNMT1 Inhibition Up-Regulates Antiviral OASL Protein during Influenza a Virus Infection. | Viruses | 2023 | 37631988 | PubTator, text mining | PubMed |
| Biopolymers and Their Application in Bioprinting Processes for Dental Tissue Engineering. | Pharmaceutics | 2023 | 37631331 | PubTator, text mining | PubMed |
| Prenatal and Neonatal Bone Health: Updated Review on Early Identification of Newborns at High Risk for Osteopenia. | Nutrients | 2023 | 37630705 | PubTator, text mining | PubMed |
| In Vitro and In Vivo Biological Assessments of 3D-Bioprinted Scaffolds for Dental Applications. | Int J Mol Sci | 2023 | 37629064 | PubTator, text mining | PubMed |
On the Value of In Vitro Cell Systems for Mechanobiology from the Perspective of Yes-Associated Protein/Transcriptional Co-Activator with a PDZ-Binding Motif and Focal Adhesion Kinase and Their Involvement in Wound Healing, Cancer, Aging, and Senescence. | Int J Mol Sci | 2023 | 37628858 | PubTator, text mining | PubMed |
| Mesenchymal Stromal Cells: Heterogeneity and Therapeutical Applications. | Cells | 2023 | 37626848 | PubTator, text mining | PubMed |
| The Action of Angiocrine Molecules Sourced from Mechanotransduction-Related Endothelial Cell Partially Explain the Successful of Titanium in Osseointegration. | J Funct Biomater | 2023 | 37623660 | PubTator, text mining | PubMed |
| Recent developments in nanomaterials for upgrading treatment of orthopedics diseases. | Front Bioeng Biotechnol | 2023 | 37621999 | PubTator, text mining | PubMed |
| Effectiveness of the production of tissue-engineered living bone graft: a comparative study using perfusion and rotating bioreactor systems. | Sci Rep | 2023 | 37612367 | PubTator, text mining | PubMed |
| Predicting the molecular mechanism-driven progression of breast cancer through comprehensive network pharmacology and molecular docking approach. | Sci Rep | 2023 | 37607964 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/3381/papers?page=16